|
HS Code |
445377 |
| Generic Name | Labetalol Hydrochloride |
| Brand Names | Trandate, Normodyne |
| Drug Class | Beta-adrenergic blocking agent (beta-blocker) |
| Mechanism Of Action | Blocks alpha-1 and non-selective beta-adrenergic receptors |
| Route Of Administration | Oral, intravenous |
| Indications | Hypertension, hypertensive emergencies |
| Molecular Formula | C19H24N2O3·HCl |
| Common Dosage Forms | Tablets, intravenous injection |
| Pregnancy Category | Category C (US FDA) |
| Side Effects | Dizziness, fatigue, nausea, orthostatic hypotension |
As an accredited Labetalol Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Labetalol Hydrochloride packaging: white, labeled box containing 10 x 20 mL amber glass vials, 5 mg/mL solution, for injection use. |
| Shipping | Labetalol Hydrochloride should be shipped in tightly sealed containers, protected from light and moisture. It is typically sent at room temperature unless otherwise specified, complying with applicable hazardous material regulations. Ensure proper labeling and documentation, and handle with appropriate safety precautions to avoid contamination or exposure during transport. |
| Storage | Labetalol Hydrochloride should be stored at controlled room temperature, ideally between 20°C to 25°C (68°F to 77°F), and protected from light and moisture. Keep the container tightly closed and away from excessive heat and humidity. Store out of reach of children and ensure that the storage area is secure to prevent unauthorized access or contamination. |
|
Purity 99%: Labetalol Hydrochloride with 99% purity is used in pharmaceutical tablet manufacturing, where it ensures consistent antihypertensive efficacy in final dosage forms. Molecular weight 364.9 g/mol: Labetalol Hydrochloride of molecular weight 364.9 g/mol is applied in intravenous formulation development, where precise dosing accuracy is achieved. Melting point 178°C: Labetalol Hydrochloride with a melting point of 178°C is used in solid-state drug development, where thermal stability during processing is maintained. Particle size D90 < 75 µm: Labetalol Hydrochloride with D90 particle size below 75 µm is utilized in oral suspension preparations, where improved drug dispersion and bioavailability are obtained. Stability at 25°C: Labetalol Hydrochloride stable at 25°C is used in long-term storage of injectable preparations, where prolonged shelf life and potency retention are realized. pH solubility profile: Labetalol Hydrochloride with optimal solubility at pH 4-6 is used in parenteral formulation, where rapid and complete dissolution is ensured. Water content <0.5%: Labetalol Hydrochloride with water content below 0.5% is used in lyophilized dosage forms, where minimal risk of hydrolytic degradation is provided. Optical purity (enantiomeric excess >98%): Labetalol Hydrochloride with enantiomeric excess above 98% is used in chiral drug screening, where enhanced pharmacological selectivity is achieved. Residual solvent <10 ppm: Labetalol Hydrochloride with residual solvent levels under 10 ppm is used in bulk API manufacturing, where safety and regulatory standards are met. Assay by HPLC >99%: Labetalol Hydrochloride with HPLC assay exceeding 99% is used in quality control of injectable solutions, where batch uniformity and regulatory compliance are assured. |
Competitive Labetalol Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Doctors have leaned on Labetalol Hydrochloride for decades to help tackle high blood pressure, both in chronic and emergency situations. This medication finds its way into clinics, emergency rooms, and pharmacies around the world, valued for its ability to address the complications that high blood pressure brings to the table. The science behind labetalol traces back to the 1970s, and since then, the compound hasn't lost ground when stacked up against newer antihypertensive drugs. It holds a unique status, often chosen when other approaches have not provided the control patients need — a testament to clinical trust earned over many years of use.
Pharmacists and clinicians see this drug every day. Someone comes in with blood pressure surging dangerously, or a pregnant woman faces hypertension that won’t settle with standard medication. Labetalol is often the answer. Its mechanism strikes a balance by blocking alpha and beta adrenergic receptors, which results in relaxed blood vessels and steadier heart rate. Many alternatives focus solely on one receptor type, but labetalol walks a different path—its dual blocking action produces results without sending heart rate plunging or causing unmanageable side effects.
At a pharmacy or medical supply distributor, labetalol hydrochloride usually appears in two primary formulations. Tablets deliver flexible dosing for outpatient and maintenance use, while injectable forms step in when quick action is critical, such as during hypertensive crises or labor. Tablet strengths commonly span 100 mg to 400 mg, letting doctors start at a low dose and adjust as patient response unfolds. The injectable vials, prepared under strict sterile conditions, support hospital protocols that demand reliability and rapid response.
The reason practitioners so frequently reach for labetalol has everything to do with real-world results. Chronic hypertension requires drugs that patients can tolerate for years without risking severe or unpredictable side effects. Labetalol's track record on this count is solid. Common side effects include mild tiredness or occasional dizziness, and these often resolve as the body adapts. Serious complications stay rare, especially compared to other blood pressure medicines that may spark coughs, ankle swelling, or sexual dysfunction.
Emergency departments keep labetalol as a go-to drug for hypertensive emergencies. In settings where speed matters, labetalol’s rapid onset and predictable effects make it a frontline option. Anesthesiologists trust it to manage blood pressure swings during surgical procedures. Maternity units rely on it when pregnant patients develop dangerously high blood pressure, since labetalol offers an option with a history of maternal and fetal safety.
Hostile blood pressure eventually damages the eyes, kidneys, and heart. Left untreated, it leads to heart failure, stroke, or kidney failure. Controlling that surge is critical, with little room for mistakes or slow reaction. Labetalol proves its worth in these situations by providing both immediate relief and manageable longer-term control. I’ve seen it prescribed when no-nonsense intervention made the difference between life and a trip to the ICU. Real stories, such as those from obstetricians sharing experiences in managing preeclampsia, underline the importance of this medication in everyday hospital life.
Many patients benefit from its distinct action. Labetalol touches both alpha and beta receptors, gently lowering blood pressure without exhausting the heart. Other medications in the antihypertensive field tend to hit just one receptor family, sometimes leaving clinicians juggling combinations to cover every base. In patients with asthma or heart block, care must guide the use of all beta-blockers, yet labetalol still finds its place thanks to its nuanced profile and the experience health teams have accumulated with it over the years.
Looking at the antihypertensive market, options like atenolol or metoprolol favor beta-blocking selectivity, sparing the alpha pathway. These drugs work well for many, but may not lower vascular resistance enough when blood pressure proves relentless. Doxazosin swings the pendulum toward alpha receptors yet doesn’t rein in heart stimulation. Labetalol’s balanced blockade leads to sustained reductions in blood pressure without sharp drops that can make patients faint, making it especially trusted in settings where such sudden changes could do harm.
This dual effect stands out in real life. Many practitioners switch to labetalol after a single-focus agent leaves blood pressure stuck at dangerously high levels. For those needing adjustments, labetalol’s dosing flexibility helps avoid complications from pushing one pathway too far while ignoring others. The result: fewer phone calls from patients startled by racing heartbeats or lightheadedness. By blending two modes of action in one medication, labetalol cuts the risk for “overshoot” side effects that can sideline recovery or daily functioning.
High blood pressure in pregnancy demands careful handling. Not every antihypertensive fits the bill — some carry risks for fetal development, while others lack evidence in severe preeclampsia. Labetalol earned a reputation through years of clinical use, supported by global guidelines. Obstetricians reach for it daily to bring dangerously high blood pressure under control and avoid maternal complications. Its safety record supports this ongoing clinical preference.
In urgent care, labetalol’s injectable option handles spikes in pressure with a steady hand. Emergency physicians don’t have time for trial and error. They need a drug that works now and keeps vital organs from suffering damage. Labetalol answers this need with proven predictability and dose-response balance. Hospital protocols build around drugs that show up consistently, and labetalol secures that spot by delivering reliable results in high-stress situations.
For people who work in medicine, every drug used tells its own story. I remember the look on family members’ faces when blood pressure numbers finally dropped from dangerous territory after nothing else seemed to work. For the patient, the relief of dizziness resolving and energy returning marks a real turning point. These moments build respect for medications like labetalol that provide genuine help when it counts.
Peer-reviewed journals back up everyday experience. Studies tracking outcomes in both stable hypertension and crisis management cite labetalol’s consistent ability to lower numbers quickly without derailing other vital signs. In preeclampsia management, ongoing trials continue to refine proper dosing, but the overall message remains clear — labetalol protects both mothers and infants when pregnancy complications escalate, setting it apart in this crucial group.
Modern clinics juggle diverse patient groups. Some people need blood pressure brought down slowly over weeks. Others walk in with levels so high that “slow and steady” isn’t an option. Labetalol’s flexible forms mean doctors can tailor the plan from gentle daily pills to fast-acting IV shots. This ability keeps it on many hospital shelves, ready to serve a wide range of needs.
Patients value flexibility too. Swallowing tablets beats waiting in an IV line for most people managing blood pressure outside the hospital. A dose that can start low and increase means fewer worries about sudden side effects. Dealing with medicine shouldn’t dominate someone’s life, which is a big reason labetalol fits well for those aiming for routine over constant medical drama.
Doctors often switch patients off some blood pressure medications due to bothersome side effects—persistent cough from ACE inhibitors, swollen feet from calcium channel blockers, or fatigue too deep to ignore from other beta-blockers. Labetalol sidesteps many of these common pitfalls. While no medication feels perfect for everyone, it tends to treat patients more gently, leading to higher rates of sticking with therapy—a key ingredient for long-term health.
All medicines carry risks, and labetalol can trigger dizziness or mild fatigue, especially in the first week or two. In rare cases, those with certain heart rhythm issues or reactive airway diseases need extra monitoring or alternative treatment. Yet the safety data collected over decades on labetalol gives both doctors and patients a level of comfort when choosing it, especially compared to newer drugs with less published long-term data or hard-to-predict interactions.
Modern medicine’s approach to hypertension owes much to lessons learned from drugs like labetalol. The story isn’t about chasing numbers alone but about protecting the organs that matter—eyes, brain, kidneys—by steadying the force inside blood vessels. Real-world evidence shows labetalol’s results speak louder than laboratory diagrams, particularly for people who need to stay active, productive, and worry-free outside of frequent doctor visits.
Ever since hypertension became a top risk factor for global disease, medications that perform well over years, not just days, earned top spots in clinical practice. Labetalol’s reputation didn’t develop overnight—it built on thousands of patient encounters, adapting both to formal guidelines and hands-on realities. The medical community’s ongoing commitment to evidence, as reflected in practice guidelines and journal reviews, points clearly to the enduring value labetalol brings.
Some success stories don’t fit easily into charts. A middle-aged teacher regained her energy after months of symptoms by switching to labetalol when first-line treatments failed. An elderly man with stubborn blood pressure challenges managed to avoid new prescriptions for heart rhythm problems after his cardiologist chose labetalol, knowing its two-pronged strategy could calm vascular tone without triggering new arrhythmias. Each of these cases underlines why concrete experience, supported by patient-centered care, matters as much as any laboratory result.
This medication also reshapes family conversations. Blood pressure management often echoes through households, with partners or parents tracking numbers, sharing data, and swapping stories. Pills like labetalol become familiar companions at the kitchen table, not just cold bottles in hallway cabinets. When a trusted drug relieves uncertainty and allows normal life to return, the impact ripples beyond the individual, restoring daily rhythms for everyone involved.
Labetalol’s story doesn’t pause with the current generation of pills and injectables. Researchers continually explore new ways to help patients stay safe and healthy. Ongoing trials examine population differences, fine-tune dosing in critical care, and look for further ways to limit possible adverse effects, especially in sensitive groups like children or those with complex chronic illness.
Regulatory agencies set benchmarks for quality and consistency in labetalol’s production. Hospitals run internal reviews to make sure every dose matches what’s expected. Clinical teams stay current with guidelines published by expert groups, making sure the way they use labetalol reflects both established standards and the latest findings. This combined focus keeps both safety and progress at the forefront.
No medication proves useful if patients can’t access it reliably. Labetalol stands out here, too. Many insurance plans cover it for both inpatient and outpatient use, acknowledging both its necessity and value. Hospitals prioritize its storage, replenishing supplies with urgency, reflecting its role in emergency protocols. Even in remote or underserved regions, health workers regularly choose labetalol, knowing its reliability and safety apply regardless of geography or resource constraints.
The push for generic forms transformed availability and affordability. As protected patents expired, reputable manufacturers expanded production, driving prices down and putting this essential medication within reach for broader segments of the population. Today, cost or availability rarely blocks access for patients who stand to benefit most.
Effective treatment relies not just on science but on communication. Doctors taking time to explain why labetalol might help a certain patient—and what to watch out for—make adherence more likely and outcomes more predictable. Patients who understand why adjustments occur feel more in control and less intimidated by the process, leading to long-lasting change rather than sporadic improvement.
Many people want to know how new medications compare with those they’ve tried before. Having real conversations about possible side effects, lifestyle compatibility, and long-term planning frames labetalol as part of a larger journey rather than a single, isolated fix. This approach builds the kind of partnership that results in better health, minimized hospitalizations, and more predictable daily living.
Global and national societies recognize labetalol’s standing, weaving it into blood pressure management protocols for adults and pregnant patients alike. Leading cardiology associations publish detailed pathways that include labetalol for both rapid intervention and ongoing management. These expert voices echo what many have experienced firsthand: labetalol meets patient needs and upholds safety standards, both in the high-stress environment of the ER and in day-to-day clinic care.
Doctors balance these recommendations with individual needs, weighing options so each person receives the right drug for their cardiovascular profile. Labetalol holds its spot by offering both medical effectiveness and practical adaptability, two qualities that matter in real lives far more than lists of theoretical benefits strung together by committees.
Every year brings new advancements in hypertension treatment, yet older drugs like labetalol maintain their relevance by delivering consistent and reliable results. Doctors and nurses see firsthand how new options sometimes come with higher costs or hard-to-predict risks, leading many to trust proven medications first for critical needs. Labetalol fits this role, continually earning its place through ongoing patient success and robust clinical support.
Keeping up with the science matters, but hands-on experience teaches lessons that don’t always show up in academic journals. Medications proven over time, especially those with multiple modes of action and broad application, remain vital even as the search for new solutions never stops. Labetalol’s impact stretches far beyond data points—it shapes stories of restored health, protects futures, and carves a unique space in the mosaic of modern medicine.
Real progress against the dangers of hypertension relies on medicines that adapt to patients’ evolving needs, work in a range of clinical situations, and stand up to the scrutiny of both data and experience. Labetalol answers that call by blending flexibility, safety, and pragmatism. As medicine shifts and patient needs change, the solid foundation laid by decades of labetalol use remains an asset.
Doctors, patients, and researchers each play a part in refining how labetalol works within broader health strategies. Direct feedback, collaborative care, and continued openness to both established drugs and new research together shape the path forward. In this mix, labetalol continues to fill needs not just in theory but in homes, hospitals, and clinics everywhere.